Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, NC, USA ; Duke Infection Control Outreach Network, Durham, NC, USA ; Duke University Prevention Epicenter Program, Durham, NC, USA ; Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Infect Drug Resist. 2012;5:133-41. doi: 10.2147/IDR.S26613. Epub 2012 Sep 24.
Klebsiella pneumoniae carbapenemases (KPCs) confer resistance to nearly all β-lactams. This broad-spectrum drug resistance mechanism has rapidly spread in the United States and is reportedly increasing elsewhere in the world. Thus, the emergence of KPC resistance is a major threat to global health. This article reviews the epidemiology and provides an overview of the dissemination of KPC-producing organisms.
肺炎克雷伯菌碳青霉烯酶(KPCs)赋予了对几乎所有β-内酰胺类药物的耐药性。这种广谱耐药机制在美国迅速传播,据报道在世界其他地方也在增加。因此,KPC 耐药性的出现对全球健康构成了重大威胁。本文综述了其流行病学,并概述了产 KPC 生物体的传播情况。